Oxford Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-8,806
Closed -$332K 420
2019
Q4
$332K Buy
+8,806
New +$396K 0.01% 1395
2019
Q1
Sell
-9,610
Closed -$573K 1700
2018
Q4
$573K Buy
+9,610
New +$829K 0.01% 1136
2017
Q3
Sell
-29,184
Closed -$2.96M 1550
2017
Q2
$2.96M Buy
29,184
+25,870
+781% +$2.79M 0.06% 409
2017
Q1
$383K Sell
3,314
-300
-8% -$34.9K 0.01% 1126
2016
Q4
$434K Buy
+3,614
New +$400K 0.02% 608
2016
Q2
Sell
-12,982
Closed -$1.46M 802
2016
Q1
$1.46M Buy
12,982
+3,797
+41% +$394K 0.04% 425
2015
Q4
$983K Sell
9,185
-15,090
-62% -$1.73M 0.02% 540
2015
Q3
$2.42M Buy
+24,275
New +$2.64M 0.08% 263
2014
Q4
Sell
-18,815
Closed -$2.79M 723
2014
Q3
$2.79M Buy
18,815
+7,844
+71% +$1.21M 0.06% 309
2014
Q2
$1.83M Sell
10,971
-2,073
-16% -$369K 0.06% 402
2014
Q1
$2.59M Buy
+13,044
New +$2.46M 0.08% 316
2013
Q4
Sell
-61,237
Closed -$10.4M 708
2013
Q3
$10.4M Sell
61,237
-61,597
-50% -$9.56M 0.23% 92
2013
Q2
$18.6M Buy
+122,834
New +$17.4M 0.5% 17

Other funds holding CLB

Oxford Asset Management's CLB Position: Q1 2020 in Review

Oxford Asset Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 8,806 shares — an estimated $332K sold.

Oxford Asset Management first reported a position in CLB in Q2 2013 and held it in 13 quarters. The position peaked at $18.6M in Q2 2013. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Oxford Asset Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 8,806 Core Laboratories shares in Q1 2020, an estimated $332K.
  • Oxford Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 13 quarters.
  • Oxford Asset Management's Core Laboratories position peaked at $18.6M in Q2 2013.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.